home / stock / achl / achl news


ACHL News and Press, Achilles Therapeutics plc

Stock Information

Company Name: Achilles Therapeutics plc
Stock Symbol: ACHL
Market: NASDAQ

Menu

ACHL ACHL Quote ACHL Short ACHL News ACHL Articles ACHL Message Board
Get ACHL Alerts

News, Short Squeeze, Breakout and More Instantly...

ACHL - Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

Combines Achilles’ best-in-class AI-driven, tumor-targeting technology with Arcturus’ world-leading self-amplifying mRNA platform Combined technologies have the potential to generate potent and durable T cell responses in pre-clinical IND-enabling studies LONDON, May...

ACHL - Achilles Therapeutics receives non-compliance notice from Nasdaq

2024-05-17 17:34:04 ET More on Achilles Therapeutics Piper downgrades Achilles to neutral, cites latest data Seeking Alpha’s Quant Rating on Achilles Therapeutics Historical earnings data for Achilles Therapeutics Financial information for Achilles The...

ACHL - ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024

2024-05-08 13:53:55 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Achilles Therapeutics (NASDAQ: ACHL ) just reported results for the first quarter of 2024. Achilles Therapeutics reported earnings per share of -30 cents. This was above t...

ACHL - Achilles Therapeutics reports Q1 GAAP EPS of -$0.30

2024-05-08 10:04:21 ET More on Achilles Therapeutics Piper downgrades Achilles to neutral, cites latest data Seeking Alpha’s Quant Rating on Achilles Therapeutics Historical earnings data for Achilles Therapeutics Financial information for Achilles The...

ACHL - Expected US Company Earnings on Wednesday, May 8th, 2024

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

ACHL - Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

– Provided interim Phase I/IIa update on clonal neoantigen reactive T cells in advanced NSCLC and melanoma – – Evaluating the benefit of enhanced host conditioning with further data expected in 2H 2024 – – Strong cash position of $112.3 million support...

ACHL - Piper downgrades Achilles to neutral, cites latest data

2024-04-05 10:44:05 ET More on Achilles Therapeutics Seeking Alpha’s Quant Rating on Achilles Therapeutics Historical earnings data for Achilles Therapeutics Financial information for Achilles Therapeutics Read the full article on Seeking Alpha ...

ACHL - US Companies Moving the Markets, Evening edition
Thu, Apr 04, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 6.5% to $0.95 on volume of 182,734,103 shares WiSA Technologies Inc. (WISA) fell 3.3% to $0.0235 on volume of 160,634,740 shares PROSHARES TRUST (SQQQ) rose 4.7% to $11.12 on volume of 151,373,755 shares...

ACHL - BRNS, UPC and KWE among mid-day movers

2024-04-04 13:06:43 ET More on Mid-day movers & stocks. Seeking Alpha’s Quant Rating on Barinthus Biotherapeutics Historical earnings data for Barinthus Biotherapeutics Financial information for Barinthus Biotherapeutics Seeking Alpha’s Quan...

ACHL - Achilles Therapeutics GAAP EPS of -$0.46 misses by $0.32

2024-04-04 12:31:26 ET More on Achilles Therapeutics Seeking Alpha’s Quant Rating on Achilles Therapeutics Historical earnings data for Achilles Therapeutics Financial information for Achilles Therapeutics Read the full article on Seeking Alpha ...

Next 10